TABLE 2.
ADC | CBV | D | D* | FA | FLAIR | f | K | MD | P | PD | Q | T1_SUB | T2_ISO | T2 | Count | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADC | −0.078 | 0.96 | −0.40 | −0.60 | 0.45 | −0.11 | −0.71 | 0.91 | 0.88 | 0.28 | −0.28 | 0.13 | 0.66 | 0.80 | 0.30 | |
CBV | 0.01 | 0.14 | −0.25 | 0.03 | 0.35 | 0.17 | −0.09 | −0.06 | 0.18 | −0.24 | 0.28 | −0.22 | −0.19 | 0.46 | ||
D | −0.31 | −0.64 | 0.46 | −0.09 | −0.68 | 0.90 | 0.88 | 0.26 | −0.31 | 0.15 | 0.64 | 0.78 | 0.40 | |||
D* | 0.30 | −0.25 | 0.15 | 0.43 | −0.38 | −0.40 | −0.25 | 0.30 | −0.09 | −0.30 | −0.49 | −0.02 | ||||
FA | −0.33 | 0.10 | 0.58 | −0.56 | −0.58 | −0.41 | 0.86 | −0.20 | −0.39 | −0.54 | −0.37 | |||||
FLAIR | 0.14 | −0.43 | 0.41 | 0.44 | 0.21 | −0.14 | 0.37 | 0.69 | 0.34 | 0.05 | ||||||
f | 0.36 | 0.01 | −0.01 | 0.07 | 0.08 | 0.27 | 0.10 | −0.07 | 0.32 | |||||||
K | −0.60 | −0.59 | −0.18 | 0.41 | −0.19 | −0.51 | −0.61 | −0.09 | ||||||||
MD | 0.98 | 0.46 | −0.28 | 0.19 | 0.62 | 0.84 | 0.36 | |||||||||
P | 0.47 | −0.31 | 0.26 | 0.59 | 0.81 | 0.36 | ||||||||||
PD | −0.47 | 0.27 | 0.02 | 0.39 | 0.00 | |||||||||||
Q | −0.23 | −0.11 | −0.34 | −0.17 | ||||||||||||
T1_SUB | 0.03 | 0.03 | 0.23 | |||||||||||||
T2_ISO | 0.69 | 0.15 | ||||||||||||||
T2 | 0.18 |
The cells with bold-face type and with gray-shaded color are those with significant correlation as indicated by Spearman’s rank correlation.
ADC: Apparent Diffusion Coefficient (DWI); CBV: Cerebral Blood Volume (DSC-MRI); D: True diffusion coefficient (IVIM);
D*: Pseudo-diffusion coefficient (IVIM); f: perfusion fraction (IVIM); K: Diffusion Kurtosis; MD: Mean Diffusivity (DTI); FA: Fractional Anisotropy (FA); P: Pure isotropic diffusion coefficient (DTI); Q: Pure anisotropic diffusion coefficient (DTI); PD: Proton Density (T2-relaxometry); T2: T2 relaxation time (T2-relaxometry); T1_SUB: Subtracted high-resolution T1w from the corresponding high-resolution contrast-enhanced T1w image; T2_ISO: High-resolution T2w image; FLAIR: Fluid-attenuated inversion recovery image.